Scientists develop model to personalize lung cancer treatment
NCT ID NCT07243899
Summary
This study looked at 3000 people with advanced lung cancer to create a prediction model. Researchers analyzed medical scans, blood tests, and lung function results to predict which patients would benefit most from immunotherapy combined with chemotherapy. The model also aims to identify patients at higher risk for serious lung inflammation side effects from treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
180 Fenglin Road
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.